Tag Archives: Prescribing

Amzeeq Now Available for Moderate to Severe Acne – Monthly Prescribing Reference

Amzeeq (minocycline; Foamix) topical foam 4% will soon be available (January 13, 2020) by prescription for the treatment of inflammatory lesions of non-nodular moderate to severe acne vulgaris in patients aged 9 years and older.  Amzeeq utilizes Foamix’s proprietary Molecule Stabilizing Technology (MST) platform to deliver minocycline, a tetracycline-class drug, in a foam formulation; it… Read More »

Genetic testing to drive personalised prescribing

Pinnacle Ventures has launched a pharmacogenomics programme to enable genetic testing to drive personalised prescribing decisions. The innovation arm of Pinnacle Midlands Health Network, a not-for-profit primary health care management company in New Zealand, is also working on embedding biomarker information into electronic health records and linking it to a clinical-decision support prescribing tool that… Read More »

Viewpoints: Any Other Public Health Problem Would Be Researched. Why Not Guns?; Remove Restrictions On Prescribing Buprenorphine To Treat Opioid Addiction

Opinion writers weigh in on these public health issues and others. Bloomberg: More Gun Research Will Lead To Better Firearm Policies A congressional subcommittee held a hearing last week on the state of gun violence research in the U.S. The conclusion? It’s shamefully incomplete.As Andrew Morral of the Rand Corporation testified, “We know little about… Read More »